Merck (FRA:6MK) FCF Margin % : -5.08% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Merck FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Merck's Free Cash Flow for the three months ended in Dec. 2023 was €-681 Mil. Merck's Revenue for the three months ended in Dec. 2023 was €13,416 Mil. Therefore, Merck's FCF Margin % for the quarter that ended in Dec. 2023 was -5.08%.

As of today, Merck's current FCF Yield % is 2.84%.

The historical rank and industry rank for Merck's FCF Margin % or its related term are showing as below:

FRA:6MK' s FCF Margin % Range Over the Past 10 Years
Min: 11.37 Med: 19.74 Max: 28.5
Current: 15.31

During the past 13 years, the highest FCF Margin % of Merck was 28.50%. The lowest was 11.37%. And the median was 19.74%.

FRA:6MK's FCF Margin % is ranked better than
84.99% of 1026 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs FRA:6MK: 15.31

Merck FCF Margin % Historical Data

The historical data trend for Merck's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck FCF Margin % Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

25.74

14.03

19.84

24.81

15.21

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															23.72	2.29	18.22	42.70	-5.08

Competitive Comparison of Merck's FCF Margin %

For the Drug Manufacturers - General subindustry, Merck's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Merck's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Merck's FCF Margin % falls into.

Merck FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Merck's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	8384.131	/	55125.455
	=	15.21 %

Merck's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-681.331	/	13415.71
	=	-5.08 %

Merck FCF Margin % Related Terms

Thank you for viewing the detailed overview of Merck's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (FRA:6MK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (FRA:6MK) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (FRA:6MK) Headlines

No Headlines